Witan Search

03/09/2026

Cancer care runs on precision. Precision runs on patient capital.

Elekta has secured public backing that says something quiet but important about European medtech. Rather than chase a headline funding round, the Stockholm radiation-medicine company has locked in long-term financing tied to a multi-year research programme. It is the kind of capital that funds the unglamorous work of making treatment more accurate, more efficient and available to more people.

✅ A loan of up to €100 million from the European Investment Bank under the TechEU programme
✅ Support for up to half of a roughly €200 million research programme running from 2026 to 2029, based mainly in Sweden and the Netherlands
✅ Technology that already treats more than two million patients every year across over 120 markets

We talk a lot about breakthrough therapies. We talk far less about the delivery systems that make them reach real patients.



📲

Stockholm-based HealthTech company Elekta has secured a loan of up to €100 million from the European Investment Bank (EIB), the European Union's financing

31/08/2026

Europe just produced its first pure-play humanoid robotics unicorn, and it did it in two years.

London-based Humanoid has raised a 133 million euro Series A, reaching a valuation of 1.1 billion euros. What makes this one worth watching is not the headline number. It is the fact that the orders are already real. When Schaeffler and Bosch are both on the cap table, and one of them has placed an order for a thousand robots, you are looking at industrial intent, not a science project.

✅ The 133 million euro round, led by Prime Movers Lab, takes total funding to 236 million euros in roughly two years
✅ Schaeffler has placed an order for one thousand robots, while Bosch has committed production capacity for one hundred thousand units over five years
✅ Beta versions of the wheeled HMND 01 robot begin rolling out to customer sites in the final quarter of this year

Someone was always going to win the mechanical race. The harder question is talent. Who staffs the controls, integration and safety roles that turn a thousand robot order into a thousand working robots.



📲

Humanoid, an AI and robotics company building industrial humanoid robots, today announced a €133 million ($152 million) Series A financing at a €1.1

27/08/2026

Inclusive beauty is becoming a measurement problem, not just a marketing one.

The Estée Lauder Companies has partnered with the University of Leeds to put real science behind shade matching. The work moves the conversation past shade counts and toward something harder. Knowing precisely when a difference in tone is actually visible to the human eye, and building that into formulation from the start.

✅ The partnership targets more precise scientific methods for shade matching across foundation, concealer and complexion products
✅ Research led by colour scientist Dr Kaida Xiao pairs advanced colour measurement with how consumers perceive tones and undertones in real conditions
✅ The aim is clear benchmarks for shade perceptibility, feeding directly into formula development across the prestige portfolio

When inclusivity becomes a measurable standard rather than a claim, how much of a competitive edge does the science itself become.



📲

The Estée Lauder Companies has partnered with the University of Leeds on research to improve shade matching across foundation, concealer and complexion products.

26/08/2026

Scale is quietly becoming the survival strategy in European speciality chemicals.

UK based William Blythe has announced a combination with US firm Metals and Additives Corporation. The stated ambition is a scaled international speciality group built around regulated and mission critical applications. In a market that has shed capacity and jobs for three years running, this reads less like opportunistic dealmaking and more like a deliberate move to matter at scale.

✅ Brings together William Blythe in the UK with MAC in the US to form one international speciality platform
✅ Combined strengths span flame retardants, smoke suppressants, catalysts, absorbents, foam technologies and polymer additives
✅ MAC founders Gregg Bennett and Mark McCaughey stay on, signalling continuity over a clean carve out

Is consolidation now the clearest route to resilience for mid sized speciality players. Or is there still room for the focused independents to win on depth.



📲

William Blythe, MAC to merge 24th August 2026 Submitted by: Andrew Warmington UK-based William Blythe has announced a “combination” with Metals & Additives (MAC) in the US. William Blythe said that this deal “creates a unique, scaled international speciality chemicals group focused on regulate...

11/08/2026

CASE is quietly one of the most interesting corners of European specialty chemicals right now. And the distributors know it.

Univar Solutions has acquired Interpur Chemicals, a European distributor of polyurethanes and powder coatings, to deepen its position across coatings, adhesives, sealants and elastomers. A small deal on paper. A clear strategic read underneath. When a global distributor buys technical, relationship-led capability in CASE, it is betting on formulation support and supply continuity as the real battleground.

What stands out:

✅ Expands Univar's specialty reach across Europe, the Middle East and Africa
✅ Adds two decades of polyurethane, resin and powder coatings expertise
✅ Targets CASE, cited as one of Europe's fastest-growing specialty segments

The lesson for the sector. Technical credibility and customer trust are becoming acquisition targets in their own right.

Is CASE the segment you would back in European chemicals right now, or is your money elsewhere?



📲

The acquisition continues a broader trend of consolidation in specialty chemical distribution as companies seek to differentiate themselves through technical expertise, application support and specialized product portfolios in addition to distribution scale.

10/08/2026

Is European beauty in retreat? The money says otherwise.

Eurazeo has lined up a €410 million investment in Aroma-Zone, the French natural and DIY beauty specialist, to accelerate its expansion. In a market where prestige groups are trimming and launching turnarounds, a nine-figure bet on clean, ingredient-led beauty tells you where the growth conviction really sits.

Why it matters:

✅ €410 million earmarked to scale a French naturals brand
✅ Backing lands as consumers keep pushing toward clean, transparent formulation
✅ Signals real investor appetite for European personal care with a differentiated story

The brands winning capital right now are the ones with a clear point of view. Not just a broad shelf.



📲

Eurazeo plans to invest around EUR410 million in Aroma-Zone, becoming its main shareholder and supporting the natural beauty company's international and omnichannel expansion.

31/07/2026

Sunnen Products and TIBO Tiefbohrtechnik have formed a strategic alliance to expand deep-hole machining capabilities globally.

Meanwhile, REACH compliance keeps reshaping the materials side of the industry — cobalt and hexavalent chromium restrictions are forcing reformulation of cemented carbide grades across the board.

Two different pressures, same takeaway: precision manufacturing is having to innovate on both performance and compliance at once.

🔗 https://mtdcnc.com/news/zcc-cutting-tools-europe/zcc-cutting-tools-europe-set-for-intertool-2026/

30/07/2026

Henkel has completed its acquisition of OLAPLEX, one of the biggest moves in premium haircare this year.

It's a clear signal of where the beauty and personal care majors are placing their bets: science-backed, cult-favorite brands with strong DTC and salon channels baked in.

Expect more consolidation as legacy players compete for share of the premium beauty market.

🔗 https://www.globalcosmeticsnews.com/global-cosmetics-news-weekly-review-week-28-july-2026/

This week's Global Cosmetics News Weekly Review covers leadership appointments, Henkel's OLAPLEX acquisition, Estée Lauder's restructuring, Gucci and L'Oréal's licensing deal, Shiseido's skin research, Superdrug's growth and the latest beauty industry developments.

29/07/2026

Business Development Manager 🧪 North UK territory, fully remote.

A European manufacturer of metalworking fluids, coolants, industrial part cleaners and rust preventatives is looking for someone to grow their presence in precision engineering.

Here is the part that matters: this is not a spec sheet and a smile. You will be on plant floors running fluid trials, troubleshooting applications, and talking chemistry with engineers and plant managers who will know immediately whether you understand their process. 🔧

It suits someone with three plus years in industrial chemical sales, real knowledge of CNC coolants and machining, and the confidence to run a territory without anyone hovering. Medium-sized business, short decision paths, direct access to leadership.

📲 Apply here: https://careers.witansearch.com/jobs/7936624-business-development-manager

28/07/2026

Country Manager, France. Full P&L, full ownership. 🇫🇷

Our client is a global manufacturer of premium commercial laundry equipment, serving hospitality, healthcare and facility management across multiple continents. France is a key market in their EMEA region, and they want someone to run it properly.

Not a caretaker role. You would lead sales strategy across direct and resale channels, own the budget, build the team, manage distributor partnerships and report straight into the VP Sales EU. 📊

What they are looking for:
✅ 5+ years in sales leadership or commercial management in EMEA
✅ A track record of building teams that hit numbers
✅ Fluent French and English
✅ Comfort with budgets, KPIs and the financial side of a country business

Bonus points for experience in commercial laundry, facility services, hospitality or B2B equipment. 🔧

This role comes with real decision-making authority and visibility to executive leadership, which is the difference between managing a market and actually running one. 💡

📲 Read more: https://careers.witansearch.com/jobs/7985747-country-manager